IN153855B - - Google Patents

Info

Publication number
IN153855B
IN153855B IN918/CAL/81A IN918CA1981A IN153855B IN 153855 B IN153855 B IN 153855B IN 918CA1981 A IN918CA1981 A IN 918CA1981A IN 153855 B IN153855 B IN 153855B
Authority
IN
India
Prior art keywords
steroid
soybean oil
inflammatory activity
fat emulsion
emulsion
Prior art date
Application number
IN918/CAL/81A
Other languages
English (en)
Inventor
Yutaka Mizushima
Kazumasa Yokoyama
Kiichiro Nabeta
Noboru Yamada
Original Assignee
Green Cross Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13270735&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN153855(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Green Cross Corp filed Critical Green Cross Corp
Publication of IN153855B publication Critical patent/IN153855B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
IN918/CAL/81A 1980-05-15 1981-08-17 IN153855B (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55064875A JPS609726B2 (ja) 1980-05-15 1980-05-15 ステロイド製剤

Publications (1)

Publication Number Publication Date
IN153855B true IN153855B (fr) 1984-08-25

Family

ID=13270735

Family Applications (1)

Application Number Title Priority Date Filing Date
IN918/CAL/81A IN153855B (fr) 1980-05-15 1981-08-17

Country Status (11)

Country Link
US (1) US4340594A (fr)
EP (1) EP0041772B2 (fr)
JP (1) JPS609726B2 (fr)
KR (1) KR850001725B1 (fr)
AT (1) ATE9870T1 (fr)
CA (1) CA1158982A (fr)
DE (1) DE3166682D1 (fr)
HK (1) HK60985A (fr)
IN (1) IN153855B (fr)
SG (1) SG37985G (fr)
ZA (1) ZA812940B (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56135416A (en) 1980-03-27 1981-10-22 Mitsubishi Chem Ind Ltd Pharmaceutical preparation for skin
JPS58201712A (ja) * 1982-05-18 1983-11-24 Green Cross Corp:The 脂肪乳剤
JPS58222014A (ja) * 1982-06-18 1983-12-23 Taisho Pharmaceut Co Ltd プロスタグランジンｅ↓１脂肪乳剤
JPS59152348A (ja) * 1983-02-19 1984-08-31 Kaken Pharmaceut Co Ltd ビフエニリルプロピオン酸エステル誘導体およびその製造法
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
JPS59141518A (ja) * 1983-02-03 1984-08-14 Taisho Pharmaceut Co Ltd プロスタグランジン脂肪乳剤
JPS59216820A (ja) * 1983-05-20 1984-12-06 Taisho Pharmaceut Co Ltd プロスタグランジン脂肪乳剤
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
JPS601122A (ja) * 1983-06-20 1985-01-07 Green Cross Corp:The ビフエニリルプロピオン酸誘導体脂肪乳剤
US4551449A (en) * 1983-11-16 1985-11-05 The Regents Of The University Of California Avoidance of the immunosuppressive and antiproliferative effects of lipid emulsions
JPS60258110A (ja) * 1984-06-05 1985-12-20 Daigo Eiyou Kagaku Kk 静脈注射可能なプロゲステロン乳化注射液
SE8403905D0 (sv) * 1984-07-30 1984-07-30 Draco Ab Liposomes and steroid esters
SE8600632D0 (sv) * 1986-02-13 1986-02-13 Kabivitrum Ab Novel pharmaceutical composition
JPH0794395B2 (ja) * 1986-06-16 1995-10-11 株式会社ミドリ十字 移植片の拒絶反応抑制剤
US5043329A (en) * 1987-02-17 1991-08-27 Board Of Regents, University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract
US5032585A (en) * 1987-02-17 1991-07-16 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for surfactant replacement therapy
US4950656A (en) * 1987-02-17 1990-08-21 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract
US5260284A (en) * 1987-02-17 1993-11-09 Board Of Regents, The University Of Texas System Methods employing unique mixtures of polar and neutral lipids and sterol for lung surfactant replacement therapy
DE4338086A1 (de) * 1993-11-08 1995-05-11 Dietl Hans Cyclosporin(e) enthaltende pharmazeutische Zubereitung zur oralen Applikation sowie Verfahren zu ihrer Herstellung
DE4338046A1 (de) * 1993-11-08 1995-05-11 Dietl Hans Fettlösliche Arzneimittel erhaltende flüssige pharmazeutische Zubereitung zur oralen Anwendung
US5554379A (en) * 1994-06-20 1996-09-10 Kv Pharmaceutical Company Long acting GI and esophageal protectant
US5670163A (en) * 1994-06-20 1997-09-23 Kv Pharmaceuticals Company Long acting GI and esophageal protectant
JPH0827018A (ja) * 1994-07-22 1996-01-30 Sanwa Kagaku Kenkyusho Co Ltd 生理活性ペプチド又は蛋白質を含有する薬剤組成物
US5554380A (en) * 1994-08-04 1996-09-10 Kv Pharmaceutical Company Bioadhesive pharmaceutical delivery system
DE69637441T2 (de) * 1995-10-17 2009-03-05 Jagotec Ag Verabreichung unlöslicher arzneistoffe
US5709878A (en) * 1996-08-02 1998-01-20 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
US7255877B2 (en) * 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
IL121647A (en) * 1997-08-28 2001-07-24 Pharmateam Dev Ltd Pharmaceutical compositions for the treatment of ocular inflammation comprising dexamethasone palmitate
US5885597A (en) * 1997-10-01 1999-03-23 Medical Research Industries,Inc. Topical composition for the relief of pain
US5869090A (en) * 1998-01-20 1999-02-09 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
IL137734A0 (en) * 1998-02-11 2001-10-31 Res Triangle Pharm Ltd Method and composition for treatment of inflammatory conditions
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
JP2002516267A (ja) 1998-05-29 2002-06-04 アールティーピー・ファーマ・インコーポレーテッド 熱的に保護された微粒子組成物及びその最終蒸気滅菌
DK1105096T3 (da) 1998-08-19 2004-03-08 Skyepharma Canada Inc Injicerbare vandige propofoldispersioner
KR20010073232A (ko) 1998-11-20 2001-07-31 추후제출 분산성 인지질로 안정화된 마이크로입자
IL148685A0 (en) * 1999-09-21 2002-09-12 Rtp Pharma Inc Surface modified particulate compositions of biologically active substances
EP1276465B1 (fr) 2000-04-20 2014-03-12 Jagotec AG Procede ameliore destine aux particules de medicament insolubles dans l'eau
JP4969761B2 (ja) 2000-08-31 2012-07-04 オバン・エナジー・リミテッド 所望粒度を持つ固体基材の小粒子および第一材料の小粒状物を含む相乗作用性混合物を製造する方法
US8586094B2 (en) 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
US6534088B2 (en) * 2001-02-22 2003-03-18 Skyepharma Canada Inc. Fibrate-statin combinations with reduced fed-fasted effects
DK1864668T3 (da) * 2006-06-01 2013-03-04 Novagali Pharma Sa Anvendelse af prodrug til okulær, intravitreal administration
EP2229174A1 (fr) * 2007-12-04 2010-09-22 Novagali Pharma S.A. Compositions comprenant un promédicament stéroïdien tel que le palmitate de dexaméthasone pour le traitement de troubles oculaires
CN106727308A (zh) * 2016-12-14 2017-05-31 广东药科大学 一种地塞米松脂质乳滴眼液及其制备方法
CN116098866A (zh) * 2022-12-15 2023-05-12 中南大学湘雅医院 一种用于治疗关节痛的糖皮质激素脂肪乳、其制法及应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1106455B (de) * 1959-05-29 1961-05-10 Upjohn Co Salbengrundlage
US3452014A (en) * 1964-08-14 1969-06-24 Upjohn Co 2,5-dimethylpyrazine p-toluenesulfonate
JPS4524514Y1 (fr) * 1965-10-15 1970-09-26
DE1668857B1 (de) * 1967-03-01 1971-09-16 Warner Lambert Pharmaceutical 6alpha,9alpha-Difluorprednisolon-17-valerat-21-acetat
JPS5850964B2 (ja) * 1978-03-07 1983-11-14 東興薬品工業株式会社 ステロイド含有クリ−ム製剤およびその製造方法
JPS5930674Y2 (ja) * 1978-05-02 1984-09-01 ヤンマー農機株式会社 脱穀機の揺動選別装置
JPS6030652B2 (ja) * 1979-05-07 1985-07-17 株式会社ミドリ十字 静脈注射用脂肪乳剤

Also Published As

Publication number Publication date
ZA812940B (en) 1982-05-26
US4340594A (en) 1982-07-20
EP0041772A3 (en) 1982-06-30
JPS609726B2 (ja) 1985-03-12
JPS56167616A (en) 1981-12-23
EP0041772B1 (fr) 1984-10-17
HK60985A (en) 1985-08-23
EP0041772B2 (fr) 1990-04-18
DE3166682D1 (en) 1984-11-22
CA1158982A (fr) 1983-12-20
ATE9870T1 (de) 1984-11-15
KR830005851A (ko) 1983-09-14
SG37985G (en) 1985-11-15
KR850001725B1 (ko) 1985-12-07
EP0041772A2 (fr) 1981-12-16

Similar Documents

Publication Publication Date Title
DE3166682D1 (en) Fat emulsion containing a steroid
SE8504967D0 (sv) A pharmaceutical composition and a method of treating the body
GB2124104B (en) Perfluorochemical emulsion artificial blood
BR8204925A (pt) Processo para fixacao de uma valvula cardiaca de tecido natural para implantacao processo para aperfeicoar as caracteristicas de fluxo de uma valvula cardiaca processo para preparacao de valvula aortica cardiaca e valvula cardiaca
FI935898A0 (fi) Foerfarande foer stimulering av immunologiskt gensvar
GR3007272T3 (fr)
FI914459A0 (fi) Stabiliserade matfetter och -oljor.
FR2555050B1 (fr) Compositions pharmaceutiques et procede de preparation de compositions de phosphatidylserine, utilisables au traitement de desordres du systeme nerveux central sans exercer d'effets sur la coagulation du sang
SE8505047D0 (sv) Fettemulsion
DE69319338D1 (de) Einfach ungesättigte fette als nahrungszusätze zur minimierung der folgen katabolischer erkrankungen
IT1208480B (it) Agente per intensificare l'azione antitumorale di un agente antitumorale.
SE7908929L (sv) Fettemulsion for intravenos injektion
IT7924778A0 (it) Procedimento per l'innesto di particelle di gomma dienica in emulsione.
DE3370762D1 (en) Compositions for use in increasing brain tyrosine levels
EP0254845A3 (fr) Stimulation d'immunité avec le chondroitine sulfate
DE3270747D1 (en) Oil, its preparation and its use, particularly in cosmetics
IT1092070B (it) Valvola per l'erogazione separata di due componenti e per la loro miscelazione all'esterno della stessa
AU2431984A (en) Shampoo Composition of Neostigmine or Pyridostigmine
TR23535A (tr) Duesuek fosfatid muhtevasina sahip yag iceren terkipler
JPS5283911A (en) Fat emulsion for intravenous injection
Dean The onset of metabolic acidosis and the optimal speeds of walking and running
LIU Pharmacological effects of mixture of Eleutherococcus(ELE) and Elscholtzia(ELS)
Vanrenterghem et al. HLA-A-matched and HLA-B-matched blood transfusions do not improve kidney allograft survival
IT1189044B (it) Procedimento per emulsionare steroi di insolubili in acqua dotati di attivita' anti-infiammatoria e prodotto ottenuto
Rubanovsky Bachmann, A. Significance of antigen-Vi in the protective properties of typhoid serum."(Comptes Rendus des S. de la S. de Biologie, t. CXXIV, 4, 1937, p. 380)